The PODD: Partnership Opportunities in Drug Delivery conference announced the keynotes for its 15th annual conference which takes place on October 27-28 at the Westin Copley Place in Boston, MA.
“In presenting a strategic-level program for R&D scientists and business development professionals, the PODD Conference is committed to securing keynotes who demonstrate excellence in science,” said Andrew Goldstein, Senior Conference Producer for the PODD Conference.
The PODD 2025 keynotes include:
Dr George Yancopoulos, Regeneron’s Co-Founder, Board Co-Chair, President and Chief Scientific Officer will join MIT’s Dr Robert Langer, a pioneer in the research and development of drug delivery technology, to discuss the state of innovation in the drug delivery industry.
Dr Lotte Bjerre Knudsen, Novo Nordisk’s Chief Scientific Advisor who drove the development of GLP-1 drugs for obesity will present on the liraglutide and semaglutide story, her approach to scientific development and where drug delivery intersects with her R&D work.
Patient Keynote Jimi Olaghere will share his journey as a patient with sickle cell disease before and after receiving CASGEVY, a CRISPR-based therapy, and his mission to make these therapies more accessible for patients globally.
Dr Mansoor Amiji, University Distinguished Professor, Northeastern University, will join the PODD Conference as the Endogenous Delivery Zeitgeist. Dr Amiji will present on endogenous targeted delivery strategies to overcome biological barriers and improve efficacy and safety.
The PODD speaking faculty includes over 100 executives from both the drug development and delivery industries with over 125 session choices including a full afternoon of drug delivery presentations from established to start-up companies.
To learn more about the event, visit PODDConference.com.
